The ⁠U.S. ⁠Food and ⁠Drug Administration has approved Merck's ​once-daily, oral, combination regimen for ‌HIV infections, the ...
Genome‑wide CRISPR screens in primary human T cells reveal human genes that promote or block HIV infection, uncovering potent ...
The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack ...
Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, ...
INSTI, tenofovir-free single-tablet maintenance option for virologically suppressed adults, expanding choices beyond ...
The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV infections, the ...
Timely HIV diagnosis and treatment are critical to preventing transmission. To help make this happen, the U.S. Centers for Disease Control and Prevention (CDC) provides funding for HIV testing to ...
The number of Latinos with HIV or AIDS in Chicago grew nearly 17% between 2020 to 2024 while other racial groups saw a drop, according to city data. This comes as public health faces a funding crunch.
The uptake of the once-every-six-month LEN in South Africa will be heavily affected by the Trump administration’s funding ...
The 63-year-old "Oslo patient" is considered to be in remission from HIV ...
HIV infection remains a global pandemic with more than 40 million people are currently infected. While treatment for HIV has ...
A 63-year-old man in Norway seems to have gotten one of the best gifts ever given by a brother: a cure to his lifelong HIV ...